Thomas Ebeling

Thomas Ebeling

Director/Board Member chez CULLINAN THERAPEUTICS, INC.

Fortune : 1 M $ au 31/03/2024

65 ans
Health Technology
Finance
Consumer Services

Profil

Thomas Ebeling is the founder of Betterlifehealthcare Ltd.
(founded in 2015), Heilpflanzenwohl AG (founded in 2016), and Te Convest AG (founded in 2018).
He is currently the Chairman of the Fund at Remagine Media Ventures, Chairman at Galderma Group AG, Director at Sivantos, Inc. (Canada), Director at Galderma Holding SA, Director at ClearVAT AG, Director at Triangle Holding III SARL, Director at SHL Medical AG, Director at Orna Therapeutics, Inc. (since 2022), Independent Director at Cullinan Oncology, Inc. (since 2017), Advisor at MPM BioImpact, Inc, Member-Supervisory Board at Schwandorfer Rohstoff- und Recycling GmbH, and Board Member & Strategic Advisor at Moonfare GmbH (since 2018).
His former positions include Chairman-Executive Board & CEO at ProSiebenSat.1 Media SE (2009-2017), Chief Executive Officer-Pharmaceuticals Division at Novartis AG (2000-2007), Chief Executive Officer at Novartis Pharmaceuticals Corp.
(2000-2007), Chief Executive Officer at Novartis Consumer Health, Inc. (2007-2008), Chief Executive Officer at Novartis Nutrition GmbH (1998-2000), Chairman at Auris Luxembourg III SA, Chairman-Supervisory Board at Apleona GmbH, Chairman-Supervisory Board at Ostbayerische Verwertungs- und Energieerzeugungsgesellschaft, Director at Idenix Pharmaceuticals LLC, Independent Director at Lonza Group AG (2013-2017), Director-National Sales & Franchise at PepsiCo Deutschland GmbH (1994-1996), Director at EQT AB, Independent Non-Executive Director at Ocean Outdoor Ltd.
(2018-2021), Independent Director at Cullinan Oncology LLC, Member-Supervisory Board at QIAGEN NV, and Member-Supervisory Board at Bayer AG (2012-2019).
He holds an undergraduate degree from the University of Hamburg (1986).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/02/2024 67 504 ( 0,16% ) 1 M $ 31/03/2024
28/02/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Thomas Ebeling

SociétésPosteDébut
CULLINAN THERAPEUTICS, INC. Director/Board Member 01/08/2017
Remagine Media Ventures/Germany/ Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member 09/03/2022
Consultant / Advisor -
Director/Board Member -
Director/Board Member 01/01/2016
Triangle Holding III SARL Director/Board Member -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Thomas Ebeling

Anciens postes connus de Thomas Ebeling

SociétésPosteFin
░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Thomas Ebeling

Formation de Thomas Ebeling

University of Hamburg Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Thomas Ebeling

Relations

100 +

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées7
QIAGEN N.V.

Health Technology

BAYER AG

Health Technology

PROSIEBENSAT.1 MEDIA SE

Consumer Services

NOVARTIS AG

Health Technology

LONZA GROUP AG

Health Technology

EQT AB

Finance

CULLINAN THERAPEUTICS, INC.

Health Technology

Entreprise privées24

Health Technology

Finance

Consumer Non-Durables

Health Technology

Health Technology

Consumer Non-Durables

Retail Trade

Health Technology

Finance

Commercial Services

Commercial Services

Finance

Finance

Industrial Services

Transportation

Heilpflanzenwohl AG

Te Convest AG

Finance

Triangle Holding III SARL

Health Technology

Health Technology

Remagine Media Ventures/Germany/

Finance

Novartis Nutrition GmbH

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Thomas Ebeling